New Research Poster Presentation 3.40
Oral Bioavailability/Bioequivalence of a Novel Investigational Extended-Release Oral Disintegrating Tablet Formulation of Amphetamine for ADHD

Thursday, October 24, 2013
Jeffrey G. Stark, PhD, Worldwide Clinical Trials, Austin, TX
Russ McMahen, NEOS Therapeutics Inc., Grand Prairie, TX
Carolyn R. Sikes, PhD, NEOS Therapeutics Inc., Grand Prairie, TX
Mark Tengler, NEOS Therapeutics Inc., Grand Prairie, TX
See more of: New Research Posters Session 3
See more of: New Research Poster
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.